Long-term safety of glycopyrrolate/eFlow ® CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study

Title
Long-term safety of glycopyrrolate/eFlow ® CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study
Authors
Keywords
COPD, eFlow, CS, Glycopyrrolate, LAMA, Nebulizer, Safety, SUN-101
Journal
RESPIRATORY MEDICINE
Volume 132, Issue -, Pages 251-260
Publisher
Elsevier BV
Online
2017-08-24
DOI
10.1016/j.rmed.2017.08.020

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started